Focused Transesophageal Echocardiography During Cardiac Arrest Resuscitation: JACC Review Topic of the Week.
Felipe Teran, Michael I Prats, Bret P Nelson...
https://pubmed.ncbi.nlm.nih.gov/32762909Actively Recruiting
Led by University of Pennsylvania · Updated on 2026-01-14
1000
Participants Needed
1
Research Sites
N/A
Total Duration
U
University of Pennsylvania
Lead Sponsor
W
Weill Medical College of Cornell University
Collaborating Sponsor
This research aims to evaluate the clinical impact and safety of focused, point-of-care transesophageal echocardiography (TEE) used during the evaluation of critically-ill adult patients in emergency departments and intensive care settings. It focuses on patients over 18 years old who receive TEE as part of their routine clinical care, especially those experiencing shock or cardiac arrest. The study also seeks to understand how TEE is used across different critical care scenarios and patient outcomes. The study observes patients receiving TEE during various clinical situations, including out-of-hospital and in-hospital cardiac arrests, initial evaluation of undifferentiated shock or acute hemodynamic decompensation, hemodynamic monitoring, and procedural guidance such as pacemaker or heart pump placement. There are no experimental treatments; instead, patients are grouped based on the clinical context in which TEE is performed. Participants are monitored from hospital admission until discharge or death, for up to 12 weeks. Researchers collect data on TEE use, clinical indications, clinician details, echocardiography findings, timing of studies, any procedure-related complications, and patient outcomes. The primary focus is on the clinical impact and safety of TEE in these critical settings. The registry supports multi-institutional collaboration and standardized data sharing to facilitate broader research in this area.
CONDITIONS
Resuscitative TEE Collaborative Registry
You may qualify if you...
You will not qualify if you...
Complete this quick 3-step screening to check your eligibility
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - From admission to discharge or death, up to 12 weeks
Participants who undergo routine clinical care and receive focused transesophageal echocardiography (TEE) during evaluation in emergency or intensive care settings are observed for clinical impact and safety.
Data collected during routine care visits
Total: 1 location
1
University of Pennsylvania
Philadelphia, Pennsylvania, United States, 19104
Actively Recruiting
C
Caleb Suh
F
Felipe Teran, MD, MSCE
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
5
Have more questions? Get in touch with our team for quick support
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Felipe Teran, Michael I Prats, Bret P Nelson...
https://pubmed.ncbi.nlm.nih.gov/32762909Felipe Teran, Katharine M Burns, Mangala Narasimhan...
https://pubmed.ncbi.nlm.nih.gov/32600742Felipe Teran, Anthony J Dean, Claire Centeno...
https://pubmed.ncbi.nlm.nih.gov/30779977Robert Arntfield, Vincent Lau, Yves Landry...
https://pubmed.ncbi.nlm.nih.gov/30189783Renata Portasio Lerner, Astrid Haaland, Judy Lin
https://pubmed.ncbi.nlm.nih.gov/31870671Emanuele Catena, Davide Ottolina, Tommaso Fossali...
https://pubmed.ncbi.nlm.nih.gov/30825552Adi Osman, Chan Pei Fong, Shaik Farid Abdull Wahab...
https://pubmed.ncbi.nlm.nih.gov/32591302Sung Oh Hwang, Pei Ge Zhao, Han Joo Choi...
https://pubmed.ncbi.nlm.nih.gov/19732038James Fair, Michael P Mallin, Aaron Adler...
https://pubmed.ncbi.nlm.nih.gov/30773413Brian K Parker, Alexis Salerno, Brian D Euerle
https://pubmed.ncbi.nlm.nih.gov/30280396